Association between antenatal corticosteroid exposure and respiratory morbidities in late preterm infants: a population-based study
Journal of Perinatal Medicine · 24.07.2026 · 54 (6) · 1054-1060
DOI: 10.1515/jpm-2025-0751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Perinatal Medicine, online erschienen am 12.05.2026. Verfasst von Hye Won Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Newborn, Betamethasone, Dexamethasone, Adrenal Cortex Hormones. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Objectives
The clinical benefit of antenatal corticosteroids (ACS) in late preterm infants remains uncertain despite guideline expansion after the ALPS trial. This study evaluated the association between ACS exposure and respiratory outcomes in late preterm infants using a nationwide Korean cohort.
Methods
We performed a population-based cohort study using linked National Health Insurance Service and National Health Screening Program data. Late preterm infants (34 +0 –36 +6 weeks) born between 2014 and 2022 were included. ACS exposure was defined as maternal betamethasone or dexamethasone administered within 7 days before delivery. Propensity scores based on maternal and neonatal characteristics were used to generate inverse probability of treatment weights. Relative risks (RRs) with 95 % confidence intervals (CIs) were estimated for respiratory outcomes.
Results
Among 53,529 infants, 6,294 (11.8 %) were exposed to ACS. Despite lower birth weight and gestational age in the ACS group, exposure was associated with reduced risks of ventilatory support (RR 0.923; 95 % CI 0.865–0.985), oxygen therapy (RR 0.827; 95 % CI 0.797–0.858), and respiratory distress syndrome (RR 0.908; 95 % CI 0.844–0.978). No significant differences were observed for transient tachypnea of the newborn (TTN) (RR 1.058; 95 % CI 0.991–1.129). Moderate-to-severe bronchopulmonary dysplasia (BPD) was rare and not associated with ACS.
Conclusions
In this nationwide cohort, ACS exposure was associated with improved acute respiratory outcomes in late preterm infants, except for TTN and moderate-to-severe BPD, providing real-world evidence supporting its effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
- Department of Clinical Pharmacology, Konkuk University Medical Center, Seoul, Korea.
- Department of Pediatrics, Eulji University, Seoul Eulji Hospital, Seoul, Korea.
ORCID-Profile: Hye Won Park, Tae-Eun Kim, Sujin Choi, Sanghyun Park, Ran Lee, Hye Sun Yoon
Zitieren
APA
Park, H. W., Kim, T. E., Choi, S., Park, S., Lee, R., & Yoon, H. S. (2026). Association between antenatal corticosteroid exposure and respiratory morbidities in late preterm infants: a population-based study. Journal of Perinatal Medicine, 54(6), 1054-1060. https://doi.org/10.1515/jpm-2025-0751
Vancouver
Park HW, Kim TE, Choi S, Park S, Lee R, Yoon HS. Association between antenatal corticosteroid exposure and respiratory morbidities in late preterm infants: a population-based study. Journal of Perinatal Medicine. 2026;54(6):1054-1060. doi:10.1515/jpm-2025-0751
BibTeX
@article{Park2026,
author = {Park, Hye Won and Kim, Tae-Eun and Choi, Sujin and Park, Sanghyun and Lee, Ran and Yoon, Hye Sun},
title = {Association between antenatal corticosteroid exposure and respiratory morbidities in late preterm infants: a population-based study},
journal = {Journal of Perinatal Medicine},
year = {2026},
volume = {54},
number = {6},
pages = {1054--1060},
doi = {10.1515/jpm-2025-0751}
}
EUVIMED